Approved Medical Conditions

Amyotrophic lateral sclerosis;

Anxiety disorders;

Autism;

Cancer, including remission therapy;

Crohn's disease;

Damage to the nervous tissue of the central nervous system (brain-spinal cord) with objective neurological indication of intractable spasticity, and other associated neuropathies;

Dyskinetic and spastic movement disorders;

Epilepsy;

Glaucoma;

HIV / AIDS;

Huntington's disease;

Inflammatory bowel disease;

Intractable seizures;

Multiple sclerosis;

Neurodegenerative diseases;

Neuropathies;

Opioid use disorder for which conventional therapeutic interventions are contraindicated or ineffective, or for which adjunctive therapy is indicated in combination with primary therapeutic interventions;

Parkinson's disease;

Post-traumatic stress disorder;

Severe chronic or intractable pain of neuropathic origin or severe chronic or intractable pain;

Sickle cell anemia;

Terminal illness; and

Tourette syndrome.